Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 2,600.00
+20.00 (0.78%)
At close: Mar 6, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 202.16 billion as of March 6, 2026. Its market cap has decreased by -44.14% in one year.
Market Cap
202.16B
Enterprise Value
285.52B
Revenue
19.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,600.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 202.16B, a decrease of -67.04%. That is a compound annual growth rate of -19.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 202.16B | -14.33% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ISU Abxis | 206.04B |
| TiumBio | 197.44B |
| Ensol Biosciences | 191.01B |
| Kangstem Biotech | 189.05B |
| QuadMedicine | 186.24B |
| Genome & Company | 223.32B |
| ABION | 259.94B |
| Bio Solution | 281.61B |